AKISERO Canadian Trademark Information
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis Providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system
Perfect for these industries
Words that describe this mark
pharmaceutical preparations treatment diseases disorders central nervous pharmaceutical preparations treatment diseases disorders central nervous attention deficit disorder attention deficit hyperactivity disorder hyperactivity cognitive impairment disorders mood disorders oppositional defiance disorder
Abandonment Notice!
On Monday, November 5, 2018,
status on the AKISERO
trademark changed to Application withdrawn.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Wednesday, May 3, 2017, a canadian trademark registration was filed for
AKISERO by PURDUE PHARMA *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1835587.
The current status of this trademark filing is Application withdrawn.
The correspondent listed for
AKISERO is
BORDEN LADNER GERVAIS LLP of *********, **********, ***** ****
The AKISERO
trademark is filed in the description of
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis
,
Providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.